CHORD Therapeutics Company Profile, Contacts & Intelligence

BiotechnologyGeneva, Ch6 employeesFounded 2014
Employees
6
Company source estimate

CHORD Therapeutics Overview

Chord Therapeutics is a clinical-stage pharmaceutical company developing drugs for patients with rare, life-threatening, and severely disabling diseases. We are advancing our lead drug candidate CRD1 under orphan drug designation for the treatment of Neuromyelitis Optica (NMO) and Myasthenia Gravis (MG). At Chord Therapeutics, we are dedicated to changing the lives of patients affected by rare diseases that often have no or only limited treatment options. We build our development programs on well-understood active substances with a history of clinical testing and use in human patients. We carefully select new indications based on a strong scientific rationale for a benefit of the mode of action of the drug in the selected disease. Taking a molecule with well studied safety and pharmacology forward to a new indication significantly reduces risk for patients and increases the likelihood for a successful development bringing new treatment options to patients and healthcare providers. The active substance in our lead medicinal product candidate CRD1 is cladribine. The extensive previous experience with cladribine substantially reduces the risk of our developments. Our cladribine product and developments are completely distinct and independent from marketed drug products that contain cladribine as an active substance. We are convinced that cladribine’s demonstrated safety and powerful, well-understood pharmacology can provide benefit in a variety of rare disorders and lead to de-risked treatment innovation. Chord Therapeutics is run by a small team of experienced professionals. We conduct our drug developments using a well-established virtual biotech business model, outsourcing services to highly specialised vendors. This allows nimble operations and ensures to obtain best quality services in an efficient and cost effective manner.

Headquarters
Geneva, Ch
Industry
Biotechnology
Founded
2014
Company Email
Available in AeroLeads

CHORD Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Compare Similar Companies to CHORD Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Gain Therapeutics Biotechnology Research 31 View company
GliaPharm SA Biotechnology Research 9 View company
Neurix SA Research Services 5 View company
Release Therapeutics Biotechnology Research 5 View company
VivoArchitect Research Services 4 View company
IDM Pharma Medical Company Pharmaceutical Manufacturing 1 View company
Eurotau Think Tanks Not listed View company
Phoqus Pharmaceuticals plc Pharmaceutical Manufacturing Not listed View company
Sapphire Therapeutics Biotechnology Research Not listed View company
Swiss Entrepreneurs & Startup Association SWESA Political Organizations Not listed View company